World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
94
Citations
29293
World Ranking
937
National Ranking
35

Medicine

D-Index
94
Citations
29399
World Ranking
10561
National Ranking
418

Louis Boon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Louis Boon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 455 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Louis Boon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Louis Boon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 94 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Louis Boon is affiliated with the University of Amsterdam in the Netherlands. Their research primarily focuses on immunology, microbiology, and medicine, with a particular emphasis on subfields including immunology, oncology, molecular biology, infectious diseases, and neurology.

The main topics of Boon's work include:

  • Immune Cell Function and Interaction
  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • IL-33, ST2, and ILC Pathways

Boon has authored numerous papers with prominent venues including bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, SSRN Electronic Journal, Journal for ImmunoTherapy of Cancer, and Cell Reports. The paper publication counts show a significant presence especially in bioRxiv and Frontiers in Immunology.

Some of their recent published works include:

  • The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes (2020, Cancer Cell)
  • Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells (2020, Immunity)
  • Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy (2021, Journal for ImmunoTherapy of Cancer)
  • Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication (2022, Immunity)
  • IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D (2020, Cancer Immunology Research)

Boon frequently collaborates with other researchers in their field. Regular co-authors include:

  • Judith E. Allen
  • Isaure Vanmeerbeek
  • Abhishek D. Garg
  • Niels Vandamme
  • Bart N. Lambrecht

The research work of Louis Boon revolves significantly around cancer immunotherapy and immune system mechanisms, especially focusing on the regulation and function of various immune cell types, immune checkpoints, and inflammatory pathways. Their studies contribute to understanding both the immune responses in cancer and autoimmune conditions, often intersecting with therapeutic strategies.

Best Publications

  • Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

    Leslie van der Fits;Sabine Mourits;Jane S. A. Voerman;Marius Kant

  • Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

    Maria T Pallotta;Ciriana Orabona;Claudia Volpi;Carmine Vacca

  • Aryl hydrocarbon receptor control of a disease tolerance defence pathway

    Alban Bessede;Alban Bessede;Marco Gargaro;Maria T. Pallotta;Davide Matino

  • The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes

    Floris Dammeijer;Mandy van Gulijk;Evalyn E. Mulder;Melanie Lukkes

  • Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs

    Alex F. de Vos;Marjan van Meurs;Herbert P. Brok;Leonie A. Boven

  • Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy.

    Ursula Grohmann;Claudia Volpi;Francesca Fallarino;Silvia Bozza

  • Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis

    Dirk Lievens;Dirk Lievens;Alma Zernecke;Tom Seijkens;Oliver Soehnlein

  • Infection with a helminth parasite attenuates autoimmunity through TGF-β-mediated suppression of Th17 and Th1 responses.

    Kevin P. Walsh;Miriam T. Brady;Conor M. Finlay;Louis Boon

  • Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages.

    Leonie A. Boven;Marjan van Meurs;Rolf G. Boot;Atul Mehta

  • Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

    Abhishek D. Garg;Lien Vandenberk;Carolien Koks;Tina Verschuere

  • CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice

    Christian Weber;Svenja Meiler;Yvonne Döring;Miriam Koch

  • A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis

    Mourad Matmati;Peggy Jacques;Jonathan Maelfait;Jonathan Maelfait;Eveline Verheugen

  • CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

    Oliver M. Grauer;Stefan Nierkens;Erik Bennink;Liza W.J. Toonen

  • Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile

    Esther Lutgens;Esther Lutgens;Dirk Lievens;Dirk Lievens;Linda Beckers;Erwin Wijnands

  • The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.

    Damya Laoui;Jiri Keirsse;Yannick Morias;Eva Van Overmeire

  • Sialic acid blockade suppresses tumor growth by enhancing T cell-mediated tumor immunity

    Christian Büll;Thomas J Boltje;Natasja Balneger;Sarah M Weischer

  • Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.

    Carolien A. Koks;Abhishek D. Garg;Michael Ehrhardt;Matteo Riva

  • Natural killer T cells in adipose tissue prevent insulin resistance

    Henk S Schipper;Maryam Rakhshandehroo;Stan F J van de Graaf;Koen Venken

  • Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells That Promote Pathogenic T Cells

    Aoife M. McGinley;Caroline E. Sutton;Sarah C. Edwards;Charlotte M. Leane

  • Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation

    Natalia B. Pikor;Jillian L. Astarita;Jillian L. Astarita;Leslie Summers-Deluca;Georgina Galicia

  • An Anti-Inflammatory Role for Plasmacytoid Dendritic Cells in Allergic Airway Inflammation

    Mirjam Kool;Menno van Nimwegen;Monique A. M. Willart;Femke Muskens

  • Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells

    Ronald Backer;Timo Schwandt;Mascha Greuter;Marije Oosting

Frequent Co-Authors

Bart N. Lambrecht
Bart N. Lambrecht Ghent University
Jan Ceuppens
Jan Ceuppens KU Leuven
Esther Lutgens
Esther Lutgens Ludwig-Maximilians-Universität München
Christian Weber
Christian Weber Ludwig-Maximilians-Universität München
Johan Garssen
Johan Garssen Utrecht University
Erik A.L. Biessen
Erik A.L. Biessen Maastricht University
Raymond Pieters
Raymond Pieters Utrecht University
Jon D. Laman
Jon D. Laman University Medical Center Groningen
Marion J.J. Gijbels
Marion J.J. Gijbels Maastricht University
Paolo Puccetti
Paolo Puccetti University of Perugia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related nursing degrees online can open diverse career opportunities. Accelerated paths such as an accelerated NP program offer a fast-track option for students with prior healthcare experience to become nurse practitioners, integrating immunology knowledge into clinical practice.

Transitioning between specialties is also possible, for example, moving from a family nurse practitioner (FNP) role to acute care requires specific certification. Understanding options like acute care certification for FNP helps professionals tailor their careers toward complex immunological patient cases.

For individuals without a nursing background, there are excellent programs like online ABSN programs for non nurses that provide the essential foundation and certification in nursing with flexible schedules designed for working adults.

Career salaries can vary widely depending on specialization and location. Referencing data on DNP salary by specialty offers insight on financial prospects in advanced immunology-related nursing roles across different states.

Best Scientists Citing Louis Boon

Trending Scientists

Recently Published Articles